ANTI SUICIDE DRUGS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Anti-Suicide Drugs Market, By Drug Class (Anti-Depressant and Anti-Anxiety Drugs, Anti-Psychotic Drugs, NMDA Antagonist, Antibiotic Analog)• By Drug Class: Anti depressants & anti anxiety drugs, Anti psychotic drugs, NMDA antagonists, Antibiotic analogs ), By Application (Hospitals, Retail Pharmacies, Online Pharmacies) , By Geography (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)

Published In: 16 Jan, 2026
Code: CMI10
Pages: 151
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Estimated Year : 2025
- Forecast Period : 2026-2033

Suicidal thoughts can be aroused due to various underlying factors such as financial burden, social issues or drug side effects. Treatment for suicidal thoughts includes psychotherapy, medications, addiction treatment, and family support. Anti-depressants and anti-psychotics are the most widely used medications for treating suicidal tendencies. According to the World Health Organization (WHO), over 800,000 people die due to suicide annually. Development of an effective anti-suicidal drug could be a major breakthrough in reducing the death toll. Currently, non-profit organizations such as Stop Suicide, Stop Youth Suicide, and American Foundation for Suicide Prevention are providing moral and social support to people with reported suicidal thoughts. This however, is ineffective until the organization is alerted of the person at risk for suicide.

Market Dynamics

Off-label use of these drugs for suicidal ideation has been a practice for years, as there are no approved anti-suicide specific drug yet. However, the dynamics is expected to change in the following few years with the launch of first oral therapeutic drug for acute suicidal ideation. This would disrupt the use of antidepressants and anti-psychotic drugs for the treatment of suicidal tendencies. Suicidal incidences are high in low and middle income countries according to the WHO 2016 statistics. Although the incidence in Asia, East Africa, and Eastern European region is high, these regions lag in terms of availability of affordable medications and healthcare facilities. Therefore developed economies of North America and Western Europe are key target regions for manufacturers in the near future. Rampant economic growth and projected strengthening of the healthcare infrastructure in emerging economies in towards the first half of the following decade is projected to shift the focus of these companies towards highly populous regions of India and China in the long run.

Key features of the study

This report provides in-depth analysis of the anti-suicide drugs and provides market size (USD Bn) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2026 – 2033, considering 2025 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global anti-suicide drugs market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans

Key companies covered as a part of this study include Pfizer, Inc., AstraZeneca plc, Eli Lilly and Company, Allergan plc, GlaxoSmithKline plc, Merck & Co., Inc., H. Lundbeck A/S, NeuroRx, Inc., and Johnson & Johnson

Insights from this report would allow marketers and the management of companies to make informed decision with respect to their future product launch, competitive scenario, geographic expansion, and marketing tactics
The global anti-suicide devices market report caters to various stakeholders in this industry, including investors, drug manufacturers, distributors and suppliers, research and consulting firms, new entrants, and financial analysts
Various strategy matrices used in analyzing the anti-suicide drugs market would provide stakeholders vital inputs to make strategic decisions accordingly

Market Segmentation

By Drug Class
- Anti‑depressants & anti‑anxiety drugs
- Anti‑psychotic drugs
- NMDA antagonists
- Antibiotic analogs
By Application
- Hospitals
- Retail Pharmacies
- Online Pharmacies
By Region
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East & Africa
  - GCC Countries
  - Israel
  - Rest of Middle East & Africa
Anti-Suicide Drugs Market Companies
- Pfizer, Inc.
- AstraZeneca plc
- Eli Lilly and Company
- Allergan plc
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Lundbeck A/S
- NeuroRx, Inc.
- Johnson & Johnson

Research Objective and assumption
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Drug Class
  - Market Snippet, By Distribution Channel
  - Market Snippet, By Geography
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Epidemiology
- Healthcare Spending
- PEST Analysis
- Pipeline Analysis
- Anti-Suicide Prevention Campaigns and Programs
Global Anti-Suicide Drugs Market, By Drug Class, 2026 - 2033 (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-O-Y Growth Analysis, 2026 - 2033
  - Segment Trends
- Anti-Depressant and Anti-Anxiety Drugs
  - Introduction
  - Market Size and Forecast, and Y-O-Y Growth, 2026 - 2033, (USD Bn)
- Anti-Psychotic Drugs
  - Introduction
  - Market Size and Forecast, and Y-O-Y Growth, 2026 - 2033, (USD Bn)
- NMDA Antagonist
  - Introduction
  - Market Size and Forecast, and Y-O-Y Growth, 2026 - 2033, (USD Bn)
- Antibiotic Analog
  - Introduction
  - Market Size and Forecast, and Y-O-Y Growth, 2026 - 2033, (USD Bn)
Global Anti-Suicide Drugs Market, By Distribution Channel, 2026 - 2033 (USD Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-O-Y Growth Analysis, 2026 - 2033
- Hospitals
  - Introduction
  - Market Size and Forecast, and Y-O-Y Growth, 2026 - 2033, (USD Bn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-O-Y Growth, 2026 - 2033, (USD Bn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-O-Y Growth, 2026 - 2033, (USD Bn)
Global Anti-Suicide Drugs Market, By Geography, 2026 - 2033 (USD Bn)
- Introduction
  - Market Share Analysis, By Region, 2026 and 2033 (%)
  - Y-O-Y Growth Analysis, For Regions, 2026 - 2033
- North America
  - Market Share Analysis, By Country, 2026 and 2033 (%)
  - Y-O-Y Growth Analysis, By Country, 2026 - 2033
- U.S.
  - Country Trends
  - Market Size and Forecast, By Drug Class, 2026 - 2033 (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Bn)
- Canada
  - Country Trends
  - Market Size and Forecast, By Drug Class, 2026 - 2033 (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Bn)
- Europe
  - Market Share Analysis, By Country, 2026 and 2033 (%)
  - Y-O-Y Growth Analysis, By Country, 2026 - 2033
- U.K.
  - Country Trends
  - Market Size and Forecast, By Drug Class, 2026 - 2033 (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Bn)
- Germany
  - Country Trends
  - Market Size and Forecast, By Drug Class, 2026 - 2033 (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Bn)
- Italy
  - Country Trends
  - Market Size and Forecast, By Drug Class, 2026 - 2033 (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Bn)
- France
  - Country Trends
  - Market Size and Forecast, By Drug Class, 2026 - 2033 (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Bn)
- Spain
  - Country Trends
  - Market Size and Forecast, By Drug Class, 2026 - 2033 (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Bn)
- Russia
  - Country Trends
  - Market Size and Forecast, By Drug Class, 2026 - 2033 (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Bn)
- Rest of Europe
  - Country Trends
  - Market Size and Forecast, By Drug Class, 2026 - 2033 (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Bn)
- Asia Pacific
  - Market Share Analysis, By Country, 2026 and 2033 (%)
  - Y-O-Y Growth Analysis, By Country, 2026 - 2033
- China
  - Country Trends
  - Market Size and Forecast, By Drug Class, 2026 - 2033 (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Bn)
- India
  - Country Trends
  - Market Size and Forecast, By Drug Class, 2026 - 2033 (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Bn)
- Japan
  - Country Trends
  - Market Size and Forecast, By Drug Class, 2026 - 2033 (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Bn)
- ASEAN
  - Country Trends
  - Market Size and Forecast, By Drug Class, 2026 - 2033 (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Bn)
- Australia
  - Country Trends
  - Market Size and Forecast, By Drug Class, 2026 - 2033 (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Bn)
- South Korea
  - Country Trends
  - Market Size and Forecast, By Drug Class, 2026 - 2033 (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Bn)
- Rest of Asia Pacific
  - Country Trends
  - Market Size and Forecast, By Drug Class, 2026 - 2033 (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Bn)
- Latin America
  - Market Share Analysis, By Country, 2026 and 2033 (%)
  - Y-O-Y Growth Analysis, By Country, 2026 - 2033
- Brazil
  - Country Trends
  - Market Size and Forecast, By Drug Class, 2026 - 2033 (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Bn)
- Mexico
  - Country Trends
  - Market Size and Forecast, By Drug Class, 2026 - 2033 (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Bn)
- Argentina
  - Country Trends
  - Market Size and Forecast, By Drug Class, 2026 - 2033 (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Bn)
- Rest of Latin America
  - Country Trends
  - Market Size and Forecast, By Drug Class, 2026 - 2033 (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Bn)
- Middle East
  - Market Share Analysis, By Country, 2026 and 2033 (%)
  - Y-O-Y Growth Analysis, By Country, 2026 - 2033
- GCC Countries
  - Country Trends
  - Market Size and Forecast, By Drug Class, 2026 - 2033 (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Bn)
- Israel
  - Country Trends
  - Market Size and Forecast, By Drug Class, 2026 - 2033 (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Bn)
- Rest of Middle East
  - Country Trends
  - Market Size and Forecast, By Drug Class, 2026 - 2033 (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Bn)
- Africa
  - Market Share Analysis, By Country, 2026 and 2033 (%)
  - Y-O-Y Growth Analysis, By Country, 2026 - 2033
- Northern Africa
  - Country Trends
  - Market Size and Forecast, By Drug Class, 2026 - 2033 (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Bn)
- Central Africa
  - Country Trends
  - Market Size and Forecast, By Drug Class, 2026 - 2033 (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Bn)
- South Africa
  - Country Trends
  - Market Size and Forecast, By Drug Class, 2026 - 2033 (USD Bn)
  - Market Size and Forecast, By Distribution Channel, 2026 - 2033 (USD Bn)
Competitive Landscape
- Heat Map Analysis
- Company Profiles
  - Pfizer, Inc.
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Key Developments
    - Market Presence
  - AstraZeneca plc
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Key Developments
    - Market Presence
  - Eli Lilly and Company
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Key Developments
    - Market Presence
  - Allergan plc
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Key Developments
    - Market Presence
  - GlaxoSmithkline plc
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Key Developments
    - Market Presence
  - Merck & Co., Inc.
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Key Developments
    - Market Presence
  - H. Lundbeck A/S
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Key Developments
    - Market Presence
  - NeuroRx, Inc.
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Key Developments
    - Market Presence
  - Johnson & Johnson
    - Company Overview
    - Product Portfolio
    - Financial Performance
    - Key Developments
    - Market Presence
Section
- References
- Research Methodology
- About us and Sales Contact

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now